Over 200 delegates attend PharmaChemical Ireland Conference in Cork
At the PharmaChemical Ireland Conference at the Radisson Blu Hotel, Cork were L to R., Colin Murphy MD, Industry and Business Magazine and Matt Moran, Director, PharmaChemical Ireland. Picture, Tony O’Connell Photography.
Minister at State, Sean Sherlock TD opened the fifth PharmaChemical Ireland (PCI), Parenteral Drugs Association (PDA), International Pharmaceutical Engineers (ISPE) Conference in the Radisson Hotel, Little Island, Cork on Wednesday the 23rd of September.
The conference, entitled Continuing the Innovation Journey throughout the Lifecycle, brought together 200 delegates to discuss the latest regulatory and innovation developments facing the sector. An international panel of speakers from Ireland, the EU and the US discussed and debated the very latest ideas and thoughts that affect the industry globally at all stages of the evolution of medicines, from discovery to the market place.
Speaking at the conference PCI Director Matt Moran pictured with Managing Director Industry & Business Magazine Colin Murphy said: “These are very exciting times for the industry in Ireland. Over €3 billion worth of capital investment has seen the sector bounce back from the patent cliff environment into a period of sustained growth. We have seen a number of high profile investments especially in the biotechnology sector. Existing sites such as Pfizer, MSD, Allergan, Brsitol Myers Squibb, Mylan and Eli Lilly have invested significant sums in expansion. They have now been joined by new entrant to the Irish market, such as Alexion, Regeneron , Jazz and Biomarin.
“As we undergo such rapid expansion the need for skills has never been greater, over 2500 new jobs will be created in the next few years. State funded initiatives such as The National Institute for Bioprocessing Research and Training (NIBRT) and pharmachem Skillnets have vital role to play in this regard. I am optimistic that if industry, Government and the academic community work together we can meet this challenge and go onto even better times ahead.”
“A taxation environment that supports enterprise, investment and R&D remains of critical importance to this sector. The Government’s stated support for the 12.5% rate of corporation tax in this country is very welcome.”
